Published in

American Society of Hematology, Blood Advances, 26(1), p. 2637-2642, 2017

DOI: 10.1182/bloodadvances.2017011536

Links

Tools

Export citation

Search in Google Scholar

Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data

Journal article published in 2017 by Matteo Rota ORCID, Paolo A. Cortesi ORCID, Roberto Crea, Alessandro Gringeri, Lorenzo G. Mantovani ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Key Points AICC has been used since 1977 to control bleeding in patients with hemophilia with inhibitors. AICC is associated with a low incidence of TEEs, especially when administered prophylactically.